Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Exercise × 1 year × Clear all

Phase

Phase NA 95 Phase 2 4 Phase 3 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Motor Activity 1

Interventions

pembrolizumab 180 Cyclophosphamide 103 Nivolumab 100 Carboplatin 85 venetoclax 66 Gemcitabine 66 Bevacizumab 64 fludarabine 62 Specimen Handling 56 Injections 56 Dexamethasone 56 Magnetic Resonance Spectroscopy 55 Paclitaxel 52 atezolizumab 50 Biopsy 49 Cisplatin 43 Ipilimumab 42 Rituximab 39 Pemetrexed 38 Docetaxel 38 Azacitidine 38 Temozolomide 36 Oxaliplatin 35 Cetuximab 35 Radiotherapy 32 Irinotecan 32 Cytarabine 32 Fluorouracil 31 durvalumab 30 Lenalidomide 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06237179 2026-03-02

EXTRA-PC

Virginia Commonwealth University

Phase 1/2 Recruiting

Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡